Gilead: A Top GARP Biotech Play, But Momentum Weakens (Downgrade)

Gilead's Q3 results exceeded expectations, with EPS of $2.47 and revenue of $7.8 billion, driven by HIV franchise ...

Agnico Eagle: Why This Best-In-Breed Gold Miner Has Plenty More Upside

Agnico Eagle stock looks undervalued with a low P/E amid the gold rally. Learn more about the gold miner's financials and ...
South Florida Reporter

Kitchen vs Bathroom Remodel – Which One Adds More Value

Understanding regional dynamics helps homeowners prioritize upgrades that align with buyer psychology while still meeting ...

The $3 trillion AI supercycle opportunity

The commodity supercycle is breaking out… copper demand from AI data centers could hit 572,000 tonnes by 2028… how Eric, ...

Berlinale Series Market: Ken Burns’ ‘American Revolution,’ Titles From Ruben Östlund and Alonso Ruizpalacios Score Selection

Mediawan, Beta Film, The Mediapro Studio, Globo, Erik Barmack, Reinvent Yellow Sales and Movistar Plus+ all scoop series ...

BioCryst Pharmaceuticals, Inc.: BioCryst Announces Preliminary Full Year 2025 ORLADEYO (berotralstat) Net Revenue of $601 Million (+37 percent y-o-y), Beating Prior Guidance Range

Excluding European ORLADEYO revenue for the full year 2025, preliminary 2025 ORLADEYO net revenue was $563 million (+43 percent y-o-y on a comparable basis)- -ORLADEYO net revenue expected to be betwe ...
New Game Network

Poker Positions: Names, Order, and a Simple Position Chart

Poker positions shape who acts first and last each round. Learn all about poker table positions (9-max and 6-max) and names.